Biology and management of chronic graft-versus-host disease

PJ Martin, SZ Pavletic - Hematopoietic Stem Cell Transplantation, 2009 - Springer
Chronic graft-versus-host disease (GvHD) is a pleiomorphic autoimmune and alloimune
syndrome with onset generally occurring between 3 and 24 months after allogeneic …

白细胞介素11 对恶性血液病患者异基因造血干细胞移植后疗效的影响

许晓军, 牛晓敏, 郭子文, 何慧清, 邱大发, 刘灿… - 中华医学杂志, 2011 - cqvip.com
目的探讨恶性血液病异基因造血干细胞移植(Allo-HSCT) 后应用重组白细胞介素(rhIL) 11
对其疗效的影响. 方法2006 年1 月至2010 年6 月中山大学附属中山医院接受Allo-HSCT 的48 …

FK506 和CSA 对异体造血干细胞在粒单白血病小鼠存活及其血清IL-2 和IL-4 水平的影响

陈静, 李春富 - 四川大学学报(医学版), 2009 - cqvip.com
目的探讨环孢霉素A (CSA) 和FK506 对造血干细胞异体移植及其对IL-2 和IL-4 表达的影响.
方法用WEH123 细胞从尾静脉注入建立小鼠粒单白血病模型. 取绿色荧光蛋白转基因鼠的骨髓 …

应用霉酚酸酯治疗异基因造血干细胞移植后移植物抗宿主病

陈欢, 刘开彦, 刘代红, 许兰平, 韩伟, 陈育红, 黄晓军 - 中华医学杂志, 2008 - cqvip.com
目的回顾性分析总结霉酚酸酯(MMF) 联合环孢素A 或普乐可复(CsA/FK506)
治疗异基因造血干细胞移植后急, 慢性移植物抗宿主病(GVHD) 的安全性和有效性. 方法44 …

Experimental and clinical experience with hematopoietic stem cell transplants

GF Georges, RF Storb - The medical bases for radiation-accident …, 2002 - books.google.com
Two approaches have been used to treat victims of radiation accidents who may have been
exposed to a broad range of irradiation exposures. One has involved hematopoietic growth …

Kutane Manifestationen der Graft-versus-Host-Reaktion

S Karrer, E Holler, RM Szeimies - Medizinische Klinik, 2001 - Springer
Zusammenfassung Die Graft-versus-Host-Reaktion (GvHD) ist eine häufige Komplikation
der allogenen Stammzelltransplantation. Man unterscheidet eine akute und eine chronische …

[PDF][PDF] Graft versus host disease (GVHD) an evidence based management guidelines

G Akpek - Turk J Haematol, 2003 - jag.journalagent.com
Hematopoietic stem cell transplantation (SCT) provides effective therapy for patients with
lymphohematopoietic, immunologic, metabolic and other disorders. Current estimates of …

皮肤慢性移植物抗宿主病的治疗

崔晶, 王飞 - 临床皮肤科杂志, 2016 - cqvip.com
随着异基因造血干细胞移植术(allogeneic haematopoietic stem cell transplantation, AHSCT)
的发展, 患者的生存时间延长. 慢性移植物抗宿主病(chronic graft-versus-host disease, c …

A limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil for prophylaxis of acute graft-versus-host disease in allogeneic stem cell …

V Gota, V Purohit, M Gurjar, L Nayak… - Cell …, 2020 - journals.sagepub.com
A universally accepted strategy for therapeutic drug monitoring (TDM) of mycophenolate
mofetil (MMF) in the prevention of acute graft-versus-host disease (aGVHD) in allogenic …

[PDF][PDF] Kronik Graft Versus Host Hastalığı: Kurtarma Tedavileri

ZT GÜVEN, L KAYNAR - Turkiye Klinikleri Hematology-Special …, 2019 - researchgate.net
Kronik graft versus host hastalığı (GVHH), allojenik kök hücre nakli sonrası en sık görülen
komplikasyondur. Tedavisinde steroidler ilk seçenek olarak kullanılmaktadır fakat hastalığı …